Freenome Initiates PROACT LUNG Clinical Study for the Early Detection of Lung Cancer Using Blood Test Developed on Multiomics Platform

/PRNewswire/ -- Freenome, a privately held company developing multiomics blood tests for early cancer detection, today announced the initiation of its PROACT...

Related Keywords

United States ,South San Francisco ,California ,Americans ,American ,Lance Baldo ,Prnewswire Freenome ,Siemens Healthineers ,Merck Kga ,Drug Administration ,Oncimmune Ltd ,United States Preventive Services Task ,Merck Kgaa ,Freenome Holdings Inc ,Novartis ,American Lung Association ,United States Preventive Services Task Force ,Hispanic Americans ,White Americans ,Lung Cancer ,Freenome Holdings ,Nc ,